CVBT has three open IND’s with the US Food and Drug Administration and four preclinical programs. They are each discussed below:
Clinical Stage Programs
CD Foot Ulcers (Chronic Diabetic Foot Ulcers)
CAD (Coronary Artery Disease)
PAD (Peripheral Arterial Disease)
Pre-Clinical Research & Development
Ischemic Disc Disease
CardioVascular BioTherapeutics, Inc. is a biopharmaceutical company developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease, and peripheral artery disease.